β-Adrenergic receptor and insulin resistance in the heart

Biomolecules and Therapeutics

Volumn 25, Issue 1, 2017, Pages 44-56

  Mangmool, Supachoke ^a   Denkaew, Tananat ^a   Parichatikanond, Warisara ^a   Kurose, Hitoshi ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

G protein coupled receptor kinase; Heart diseases; Insulin resistance; Protein kinase A; adrenergic receptor; blockers

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ARRESTIN; G PROTEIN COUPLED RECEPTOR; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR;

ARTICLE; BETA ADRENERGIC STIMULATION; CARDIAC INSULIN RESISTANCE; DISEASE ASSOCIATION; GLUCOSE TRANSPORT; HEART DISEASE; HEART FAILURE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRACELLULAR SIGNALING; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS;

EID: 85008400398     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2016.128     Document Type: Article

References (136)

1. Akhter, S. A., Luttrell, L. M., Rockman, H. A., Iaccarino, G., Lefkowitz, R. J. and Koch, W. J. (1998) Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280, 574-577.
2. Akikawa, R., Nawano, M., Gu, Y., Katagiri, H., Asano, T., Zhu, W., Nagai, R. and Komuro, I. (2000) Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation 102, 2873-2879.
3. Anis, Y., Leshem, O., Reuveni, H., Wexler, I., Ben Sasson, R., Yahalom, B., Laster, M., Raz, I., Ben Sasson, S., Shafrir, E. and Ziv, E. (2004) Antidiabetic effect of novel modulating peptides of G-protein-coupled kinase in experimental models of diabetes. Diabetologia 47, 1232-1244.
4. Backer, J. M., Myers, M. G., Jr., Shoelson, S. E., Chin, D. J., Sun, X. J., Miralpeix, M., Hu, P., Margolis, B., Skolnik, E. Y. and Schlessinger, J. (1992) Phosphatidylinositol 3’-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 11, 3469-3479.
5. Bangalore, S., Messerli, F. H., Kostis, J. B. and Pepine, C. J. (2007) Cardiovascular protection using β-blockers: a critical review of the evidence. J. Am. Coll. Cardiol. 50, 563-572.
6. Beaulieu, J. M., Sotnikova, T. D., Marion, S., Lefkowitz, R. J., Gainetdinov, R. R. and Caron, M. G. (2005) An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 122, 261-273.
7. Becker, A. B. and Roth, R. A. (1990) Insulin receptor structure and function in normal and pathological conditions. Annu. Rev. Med. 41, 99-115.
8. Belke, D. D., Larsen, T. S., Gibbs, E. M. and Severson, D. L. (2000) Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am. J. Physiol. Endocrinol. Metab. 279, E1104-E1113.
9. Bell, D. S. (2003) Heart failure: the frequent, forgotten, and often fatal complication of diabetes. Diabetes Care 26, 2433-2441.
10. Benovic, J. L., Strasser, R. H., Caron, M. G. and Lefkowitz, R. J. (1986) β-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc. Natl. Acad. Sci. U.S.A. 83, 2797-2801.
11. Bevan, P. (2001) Insulin signalling. J. Cell Sci. 114, 1429-1430.
12. Boden, G. and Shulman, G. I. (2002) Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and β-cell dysfunction. Eur. J. Clin. Invest. 32 Suppl 3, 14-23.
13. Bos, J. L. (2006) Epac proteins: multi-purpose cAMP targets. Trends Biochem. Sci. 31, 680-686.
14. Boudina, S., Bugger, H., Sena, S., O’Neill, B. T., Zaha, V. G., Ilkun, O., Wright, J. J., Mazumder, P. K., Palfreyman, E., Tidwell, T. J., Theobald, H., Khalimonchuk, O., Wayment, B., Sheng, X., Rodnick, K. J., Centini, R., Chen, D., Litwin, S. E., Weimer, B. E. and Abel, E. D. (2009) Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 119, 1272-1283.
15. Chiasson, J. L., Shikama, H., Chu, D. T. and Exton, J. H. (1981) Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. J. Clin. Invest. 68, 706-713.
16. Chirieac, D. V., Chirieac, L. R., Corsetti, J. P., Cianci, J., Sparks, C. E. and Sparks, J. D. (2000) Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production. Am. J. Physiol. Endocrinol. Metab. 279, E1003-E1011.
17. Ciccarelli, M., Chuprun, J. K., Rengo, G., Gao, E., Wei, Z., Peroutka, R. J., Gold, J. I., Gumpert, A., Chen, M., Otis, N. J., Dorn, G. W., 2nd, Trimarco, B., Iaccarino, G. and Koch, W. J. (2011) G proteincoupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation 123, 1953-1962.
18. Cipolletta, E., Campanile, A., Santulli, G., Sanzari, E., Leosco, D., Campiglia, P., Trimarco, B. and Iaccarino, G. (2009) The G protein coupled receptor kinase 2 plays an essential role in β-adrenergic receptor-induced insulin resistance. Cardiovasc. Res. 84, 407-415.
19. Coats, A. J. and Anker, S. D. (2000) Insulin resistance in chronic heart failure. J. Cardiovasc. Pharmacol. 35, S9-S14.
20. Communal, C., Singh, K., Sawyer, D. B. and Colucci, W. S. (1999) Opposing effects of β1-and β2-adrenergic receptors on cardiac myocyte apoptosis: role of a pertussis toxin-sensitive G protein. Circulation 100, 2210-2212.
21. Czech, M. P. and Corvera, S. (1999) Signaling mechanisms that regulate glucose transport. J. Biol. Chem. 274, 1865-1868.
22. De Meyts, P. (2004) Insulin and its receptor: structure, function and evolution. Bioessays 26, 1351-1362.
23. DeFronzo, R. A. (2004) Pathogenesis of type 2 diabetes mellitus. Med. Clin. North Am. 88, 787-835.
24. DeFronzo, R. A. and Tripathy, D. (2009) Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care 32 Suppl 2, S157-S163.
25. Deibert, D. C. and DeFronzo, R. A. (1980) Epinephrine-induced insulin resistance in man. J. Clin. Invest. 65, 717-721.
26. Doggrell, S. A. and Henderson, C. J. (1998) The offset of β-adrenoceptor antagonism of the responses of the rat right ventricle to isoprenaline. J. Auton. Pharmacol. 18, 263-269.
27. Eckel, R. H., Grundy, S. M. and Zimmet, P. Z. (2005) The metabolic syndrome. Lancet 365, 1415-1428.
28. Feener, E. P. and King, G. L. (1997) Vascular dysfunction in diabetes mellitus. Lancet 350 Suppl 1, SI9-SI13.
29. Ferguson, S. S., Downey, W. E., 3rd, Colapietro, A. M., Barak, L. S., Menard, L. and Caron, M. G. (1996) Role of β-arrestin in mediating agonist-promoted G protein-coupled receptor internalization. Science 271, 363-366.
30. Ginsberg, H. N. (2000) Insulin resistance and cardiovascular disease. J. Clin. Invest. 106, 453-458.
31. Hall, R. A., Premont, R. T., Chow, C. W., Blitzer, J. T., Pitcher, J. A., Claing, A., Stoffel, R. H., Barak, L. S., Shenolikar, S., Weinman, E. J., Grinstein, S. and Lefkowitz, R. J. (1998) The β2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange. Nature 392, 626-630.
32. Hayashi, K., Shibata, K., Morita, T., Iwasaki, K., Watanabe, M. and Sobue, K. (2004) Insulin receptor substrate-1/SHP-2 interaction, a phenotype-dependent switching machinery of insulin-like growth factor-I signaling in vascular smooth muscle cells. J. Biol. Chem. 279, 40807-40818.
33. Heather, L. C., Catchpole, A. F., Stuckey, D. J., Cole, M. A., Carr, C. A. and Clarke, K. (2009) Isoproterenol induces in vivo functional and metabolic abnormalities: similar to those found in the infarcted rat heart. J. Physiol. Pharmacol. 60, 31-39.
34. Heck, P. M. and Dutka, D. P. (2009) Insulin resistance and heart failure. Curr. Heart Fail. Rep. 6, 89-94.
35. Hillier, T. A. and Pedula, K. L. (2003) Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 26, 2999-3005.
36. Hoffmann, C., Leitz, M. R., Oberdorf-Maass, S., Lohse, M. J. and Klotz, K. N. (2004) Comparative pharmacology of human β-adrenergic receptor subtypes-characterization of stably transfected receptors in CHO cells. Naunyn Schmiedebergs Arch. Pharmacol. 369, 151-159.
37. How, O. J., Aasum, E., Severson, D. L., Chan, W. Y., Essop, M. F. and Larsen, T. S. (2006) Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 55, 466-473.
38. Hu, L. A., Tang, Y., Miller, W. E., Cong, M., Lau, A. G., Lefkowitz, R. J. and Hall, R. A. (2000) β1-adrenergic receptor association with PSD-95. Inhibition of receptor internalization and facilitation of β1-adrenergic receptor interaction with N-methyl-D-aspartate receptors. J. Biol. Chem. 275, 38659-38666.
39. Iaccarino, G., Barbato, E., Cipolleta, E., Esposito, A., Fiorillo, A., Koch, W. J. and Trimarco, B. (2001) Cardiac βARK1 upregulation induced by chronic salt deprivation in rats. Hypertension 38, 255-260.
40. Iaccarino, G., Barbato, E., Cipolletta, E., De Amicis, V., Margulies, K. B., Leosco, D., Trimarco, B. and Koch, W. J. (2005a) Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur. Heart J. 26, 1752-1758.
41. Iaccarino, G., Trimarco, V., Lanni, F., Cipolletta, E., Izzo, R., Arcucci, O., De Luca, N. and Di Renzo, G. (2005b) β-Blockade and increased dyslipidemia in patients bearing Glu27 variant of β2 adrenergic receptor gene. Pharmacogenomics J. 5, 292-297.
42. Ishibashi, K. I., Imamura, T., Sharma, P. M., Huang, J., Ugi, S. and Olefsky, J. M. (2001) Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes. J. Clin. Invest. 107, 1193-1202.
43. Ishiyama-Shigemoto, S., Yamada, K., Yuan, X., Ichikawa, F. and Nonaka, K. (1999) Association of polymorphisms in the β2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 42, 98-101.
44. Izzo, R., Cipolletta, E., Ciccarelli, M., Campanile, A., Santulli, G., Palumbo, G., Vasta, A., Formisano, S., Trimarco, B. and Iaccarino, G. (2008) Enhanced GRK2 expression and desensitization of βAR vasodilatation in hypertensive patients. Clin. Transl. Sci. 1, 215-220.
45. Jellinger, P. S. (2007) Metabolic consequences of hyperglycemia and insulin resistance. Clin. Cornerstone 8 Suppl 7, S30-S42.
46. Joost, H. G. and Steinfelder, H. J. (1987) Forskolin inhibits insulin-stimulated glucose transport in rat adipose cells by a direct interaction with the glucose transporter. Mol. Pharmacol. 31, 279-283.
47. Juhan-Vague, I., Alessi, M. C. and Vague, P. (1996) Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus. Ann. Med. 28, 371-380.
48. Kaestner, K. H., Flores-Riveros, J. R., McLenithan, J. C., Janicot, M. and Lane, M. D. (1991) Transcriptional repression of the mouse insulin-responsive glucose transporter (GLUT4) gene by cAMP. Proc. Natl. Acad. Sci. U.S.A. 88, 1933-1937.
49. Kashiwagi, A., Huecksteadt, T. P. and Foley, J. E. (1983) The regulation of glucose transport by cAMP stimulators via three different mechanisms in rat and human adipocytes. J. Biol. Chem. 258, 13685-13692.
50. Kitamura, T., Ogawa, W., Sakaue, H., Hino, Y., Kuroda, S., Takata, M., Matsumoto, M., Maeda, T., Konishi, H., Kikkawa, U. and Kasuga, M. (1998) Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport. Mol. Cell. Biol. 18, 3708-3717.
51. Klein, J., Fasshauer, M., Ito, M., Lowell, B. B., Benito, M. and Kahn, C. R. (1999) β3-adrenergic stimulation differentially inhibits insulin signaling and decreases insulin-induced glucose uptake in brown adipocytes. J. Biol. Chem. 274, 34795-34802.
52. Kobayashi, H., Narita, Y., Nishida, M. and Kurose, H. (2005) β-arrestin2 enhances β2-adrenergic receptor-mediated nuclear translocation of ERK. Cell. Signal. 17, 1248-1253.
53. Koch, W. J., Rockman, H. A., Samama, P., Hamilton, R. A., Bond, R. A., Milano, C. A. and Lefkowitz, R. J. (1995) Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a β ARK inhibitor. Science 268, 1350-1353.
54. Kohn, A. D., Barthel, A., Kovacina, K. S., Boge, A., Wallach, B., Summers, S. A., Birnbaum, M. J., Scott, P. H., Lawrence, J. C., Jr. and Roth, R. A. (1998) Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J. Biol. Chem. 273, 11937-11943.
55. Kohn, A. D., Summers, S. A., Birnbaum, M. J. and Roth, R. A. (1996) Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 271, 31372-31378.
56. Kolter, T., Uphues, I. and Eckel, J. (1997) Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am. J. Physiol. 273, E59-E67.
57. Kotani, K., Ogawa, W., Matsumoto, M., Kitamura, T., Sakaue, H., Hino, Y., Miyake, K., Sano, W., Akimoto, K., Ohno, S. and Kasuga, M. (1998) Requirement of atypical protein kinase clambda for insulin stimulation of glucose uptake but not for Akt activation in 3T3-L1 adipocytes. Mol. Cell. Biol. 18, 6971-6982.
58. Krupnick, J. G. and Benovic, J. L. (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu. Rev. Pharmacol. Toxicol. 38, 289-319.
59. Kuboki, K., Jiang, Z. Y., Takahara, N., Ha, S. W., Igarashi, M., Yamauchi, T., Feener, E. P., Herbert, T. P., Rhodes, C. J. and King, G. L. (2000) Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101, 676-681.
60. Lager, I. (1991) The insulin-antagonistic effect of the counterregulatory hormones. J. Intern. Med. Suppl. 735, 41-47.
61. Lamounier-Zepter, V., Ehrhart-Bornstein, M. and Bornstein, S. R. (2006) Insulin resistance in hypertension and cardiovascular disease. Best Pract. Res. Clin. Endocrinol. Metab. 20, 355-367.
62. Lee, A. D., Hansen, P. A., Schluter, J., Gulve, E. A., Gao, J. and Holloszy, J. O. (1997) Effects of epinephrine on insulin-stimulated glucose uptake and GLUT-4 phosphorylation in muscle. Am. J. Physiol. 273, C1082-C1087.
63. Lee, J. and Pilch, P. F. (1994) The insulin receptor: structure, function, and signaling. Am. J. Physiol. 266, C319-C334.
64. Lefkowitz, R. J., Rajagopal, K. and Whalen, E. J. (2006) New roles for β-arrestins in cell signaling: not just for seven-transmembrane receptors. Mol. Cell 24, 643-652.
65. Lefkowitz, R. J. and Shenoy, S. K. (2005) Transduction of receptor signals by β-arrestins. Science 308, 512-517.
66. Luan, B., Zhao, J., Wu, H., Duan, B., Shu, G., Wang, X., Li, D., Jia, W., Kang, J. and Pei, G. (2009) Deficiency of a β-arrestin-2 signal complex contributes to insulin resistance. Nature 457, 1146-1149.
67. Luttrell, L. M., Ferguson, S. S., Daaka, Y., Miller, W. E., Maudsley, S., Della Rocca, G. J., Lin, F., Kawakatsu, H., Owada, K., Luttrell, D. K., Caron, M. G. and Lefkowitz, R. J. (1999) β-arrestin-dependent formation of β2 adrenergic receptor-Src protein kinase complexes. Science 283, 655-661.
68. Mangmool, S., Denkaew, T., Phosri, S., Pinthong, D., Parichatikanond, W., Shimauchi, T. and Nishida, M. (2016) Sustained βAR stimulation mediates cardiac insulin resistance in a PKA-dependent manner. Mol. Endocrinol. 30, 118-132.
69. Mangmool, S., Haga, T., Kobayashi, H., Kim, K. M., Nakata, H., Nishida, M. and Kurose, H. (2006) Clathrin required for phosphorylation and internalization of β2-adrenergic receptor by G protein-coupled receptor kinase 2 (GRK2). J. Biol. Chem. 281, 31940-31949.
70. Mangmool, S., Shukla, A. K. and Rockman, H. A. (2010) β-Arrestindependent activation of Ca2+/calmodulin kinase II after β1-adrenergic receptor stimulation. J. Cell Biol. 189, 573-587.
71. Marshall, J. D., Bronson, R. T., Collin, G. B., Nordstrom, A. D., Maffei, P., Paisey, R. B., Carey, C., Macdermott, S., Russell-Eggitt, I., Shea, S. E., Davis, J., Beck, S., Shatirishvili, G., Mihai, C. M., Hoeltzenbein, M., Pozzan, G. B., Hopkinson, I., Sicolo, N., Naggert, J. K. and Nishina, P. M. (2005) New Alstrom syndrome phenotypes based on the evaluation of 182 cases. Arch. Intern. Med. 165, 675-683.
72. Matthaei, S., Stumvoll, M., Kellerer, M. and Haring, H. U. (2000) Pathophysiology and pharmacological treatment of insulin resistance. Endocr. Rev. 21, 585-618.
73. Mazumder, P. K., O’Neill, B. T., Roberts, M. W., Buchanan, J., Yun, U. J., Cooksey, R. C., Boudina, S. and Abel, E. D. (2004) Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 53, 2366-2374.
74. McFarlane, S. I., Banerji, M. and Sowers, J. R. (2001) Insulin resistance and cardiovascular disease. J. Clin. Endocrinol. Metab. 86, 713-718.
75. Mingrone, G., DeGaetano, A., Greco, A. V., Capristo, E., Benedetti, G., Castagneto, M. and Gasbarrini, G. (1997) Reversibility of insulin resistance in obese diabetic patients: role of plasma lipids. Diabetologia 40, 599-605.
76. Montagnani, M., Ravichandran, L. V., Chen, H., Esposito, D. L. and Quon, M. J. (2002) Insulin receptor substrate-1 and phosphoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol. Endocrinol. 16, 1931-1942.
77. Morisco, C., Condorelli, G., Trimarco, V., Bellis, A., Marrone, C., Condorelli, G., Sadoshima, J. and Trimarco, B. (2005) Akt mediates the cross-talk between β-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ. Res. 96, 180-188.
78. Morisco, C., Lembo, G. and Trimarco, B. (2006) Insulin resistance and cardiovascular risk: New insights from molecular and cellular biology. Trends Cardiovasc. Med. 16, 183-188.
79. Morisco, C., Marrone, C., Trimarco, V., Crispo, S., Monti, M. G., Sadoshima, J. and Trimarco, B. (2007) Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression. Cardiovasc. Res. 76, 453-464.
80. Mulder, A. H., Tack, C. J., Olthaar, A. J., Smits, P., Sweep, F. C. and Bosch, R. R. (2005) Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation. Am. J. Physiol. Endocrinol. Metab. 289, E627-E633.
81. Murray, A. J., Anderson, R. E., Watson, G. C., Radda, G. K. and Clarke, K. (2004) Uncoupling proteins in human heart. Lancet 364, 1786-1788.
82. Murray, A. J., Lygate, C. A., Cole, M. A., Carr, C. A., Radda, G. K., Neubauer, S. and Clarke, K. (2006) Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart. Cardiovasc. Res. 71, 149-157.
83. Myers, M. G., Jr., Wang, L. M., Sun, X. J., Zhang, Y., Yenush, L., Schlessinger, J., Pierce, J. H. and White, M. F. (1994) Role of IRS-1-GRB-2 complexes in insulin signaling. Mol. Cell. Biol. 14, 3577-3587.
84. Nakaya, M., Chikura, S., Watari, K., Mizuno, N., Mochinaga, K., Mangmool, S., Koyanagi, S., Ohdo, S., Sato, Y., Ide, T., Nishida, M. and Kurose, H. (2012) Induction of cardiac fibrosis by β-blocker in G protein-independent and G protein-coupled receptor kinase 5/β-arrestin2-dependent signaling pathways. J. Biol. Chem. 287, 35669-35677.
85. Nichols, G. A., Gullion, C. M., Koro, C. E., Ephross, S. A. and Brown, J. B. (2004) The incidence of congestive heart failure in type 2 diabetes: an update. Diabetes Care 27, 1879-1884.
86. Nikolaidis, L. A., Poornima, I., Parikh, P., Magovern, M., Shen, Y. T. and Shannon, R. P. (2006) The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy. J. Am. Coll. Cardiol. 47, 1871-1881.
87. Nikolaidis, L. A., Sturzu, A., Stolarski, C., Elahi, D., Shen, Y. T. and Shannon, R. P. (2004) The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy. Cardiovasc. Res. 61, 297-306.
88. Nonogaki, K. (2000) New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 43, 533-549.
89. Oestreich, E. A., Wang, H., Malik, S., Kaproth-Joslin, K. A., Blaxall, B. C., Kelley, G. G., Dirksen, R. T. and Smrcka, A. V. (2007) Epac-mediated activation of phospholipase C(epsilon) plays a critical role in β-adrenergic receptor-dependent enhancement of Ca2+ mobilization in cardiac myocytes. J. Biol. Chem. 282, 5488-5495.
90. Ohtake, T., Yokoyama, I., Watanabe, T., Momose, T., Serezawa, T., Nishikawa, J. and Sasaki, Y. (1995) Myocardial glucose metabolism in noninsulin-dependent diabetes mellitus patients evaluated by FDG-PET. J. Nucl. Med. 36, 456-463.
91. Olefsky, J., Farquhar, J. W. and Reaven, G. (1973) Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes 22, 507-513.
92. Paolisso, G., De Riu, S., Marrazzo, G., Verza, M., Varricchio, M. and D’Onofrio, F. (1991) Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure. Metabolism 40, 972-977.
93. Paolisso, G., Manzella, D., Rizzo, M. R., Ragno, E., Barbieri, M., Varricchio, G. and Varricchio, M. (2000) Elevated plasma fatty acid concentrations stimulate the cardiac autonomic nervous system in healthy subjects. Am. J. Clin. Nutr. 72, 723-730.
94. Park, S. Y., Cho, Y. R., Kim, H. J., Higashimori, T., Danton, C., Lee, M. K., Dey, A., Rothermel, B., Kim, Y. B., Kalinowski, A., Russell, K. S. and Kim, J. K. (2005) Unraveling the temporal pattern of diet-induced insulin resistance in individual organs and cardiac dysfunction in C57BL/6 mice. Diabetes 54, 3530-3540.
95. Paternostro, G., Camici, P. G., Lammerstma, A. A., Marinho, N., Baliga, R. R., Kooner, J. S., Radda, G. K. and Ferrannini, E. (1996) Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography. J. Clin. Invest. 98, 2094-2099.
96. Paternostro, G., Clarke, K., Heath, J., Seymour, A. M. and Radda, G. K. (1995) Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc. Res. 30, 205-211.
97. Paternostro, G., Pagano, D., Gnecchi-Ruscone, T., Bonser, R. S. and Camici, P. G. (1999) Insulin resistance in patients with cardiac hypertrophy. Cardiovasc. Res. 42, 246-253.
98. Penela, P., Ribas, C. and Mayor, F., Jr. (2003) Mechanisms of regulation of the expression and function of G protein-coupled receptor kinases. Cell. Signal. 15, 973-981.
99. Penn, R. B., Pronin, A. N. and Benovic, J. L. (2000) Regulation of G protein-coupled receptor kinases. Trends Cardiovasc. Med. 10, 81-89.
100. Pierce, K. L., Premont, R. T. and Lefkowitz, R. J. (2002) Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639-650.
101. Postic, C., Leturque, A., Rencurel, F., Printz, R. L., Forest, C., Granner, D. K. and Girard, J. (1993) The effects of hyperinsulinemia and hyperglycemia on GLUT4 and hexokinase II mRNA and protein in rat skeletal muscle and adipose tissue. Diabetes 42, 922-929.
102. Randle, P. J., Garland, P. B., Hales, C. N. and Newsholme, E. A. (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1, 785-789.
103. Reaven, G. M. (1991) Insulin resistance, hyperinsulinemia, and hypertriglyceridemia in the etiology and clinical course of hypertension. Am. J. Med. 90, 7S-12S.
104. Rockman, H. A., Koch, W. J. and Lefkowitz, R. J. (2002) Seven-transmembrane-spanning receptors and heart function. Nature 415, 206-212.
105. Salazar, N. C., Chen, J. and Rockman, H. A. (2007) Cardiac GPCRs: GPCR signaling in healthy and failing hearts. Biochim. Biophys. Acta 1768, 1006-1018.
106. Sarbassov, D. D. and Peterson, C. A. (1998) Insulin receptor substrate-1 and phosphatidylinositol 3-kinase regulate extracellular signal-regulated kinase-dependent and -independent signaling pathways during myogenic differentiation. Mol. Endocrinol. 12, 1870-1878.
107. Sasaoka, T. and Kobayashi, M. (2000) The functional significance of Shc in insulin signaling as a substrate of the insulin receptor. Endocr. J. 47, 373-381.
108. Savage, D. B., Petersen, K. F. and Shulman, G. I. (2005) Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 45, 828-833.
109. Scherrer, U., Randin, D., Vollenweider, P., Vollenweider, L. and Nicod, P. (1994) Nitric oxide release accounts for insulin’s vascular effects in humans. J. Clin. Invest. 94, 2511-2515.
110. Sesti, G. (2006) Pathophysiology of insulin resistance. Best Pract. Res. Clin. Endocrinol. Metab. 20, 665-679.
111. Shah, A. and Shannon, R. P. (2003) Insulin resistance in dilated cardiomyopathy. Rev. Cardiovasc. Med. 4 Suppl 6, S50-S57.
112. Shiina, T., Kawasaki, A., Nagao, T. and Kurose, H. (2000) Interaction with β-arrestin determines the difference in internalization behavior between β1-and β2-adrenergic receptors. J. Biol. Chem. 275, 29082-29090.
113. Sucharov, C. C., Mariner, P. D., Nunley, K. R., Long, C., Leinwand, L. and Bristow, M. R. (2006) A β1-adrenergic receptor CaM kinase II-dependent pathway mediates cardiac myocyte fetal gene induction. Am. J. Physiol. Heart Circ. Physiol. 291, H1299-H1308.
114. Swan, J. W., Anker, S. D., Walton, C., Godsland, I. F., Clark, A. L., Leyva, F., Stevenson, J. C. and Coats, A. J. (1997) Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure. J. Am. Coll. Cardiol. 30, 527-532.
115. Swan, J. W., Walton, C., Godsland, I. F., Clark, A. L., Coats, A. J. and Oliver, M. F. (1994) Insulin resistance in chronic heart failure. Eur. Heart J. 15, 1528-1532.
116. Taguchi, K., Matsumoto, T., Kamata, K. and Kobayashi, T. (2012) G protein-coupled receptor kinase 2, with β-arrestin 2, impairs insulin-induced Akt/endothelial nitric oxide synthase signaling in ob/ob mouse aorta. Diabetes 61, 1978-1985.
117. Taniguchi, C. M., Emanuelli, B. and Kahn, C. R. (2006) Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7, 85-96.
118. Thomas, J. A. and Marks, B. H. (1978) Plasma norepinephrine in congestive heart failure. Am. J. Cardiol. 41, 233-243.
119. Trovati, M. and Anfossi, G. (1998) Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells. Diabetologia 41, 609-622.
120. Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L. M., Dull, T. J., Gray, A., Coussens, L., Liao, Y. C., Tsubokawa, M., Mason, P. H., Seeburg, C., Grunfeld, O., Rosen, M. and Ramachandran, J. (1985) Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313, 756-761.
121. Ungerer, M., Bohm, M., Elce, J. S., Erdmann, E. and Lohse, M. J. (1993) Altered expression of β-adrenergic receptor kinase and β 1-adrenergic receptors in the failing human heart. Circulation 87, 454-463.
122. Ungerer, M., Parruti, G., Bohm, M., Puzicha, M., DeBlasi, A., Erdmann, E. and Lohse, M. J. (1994) Expression of β-arrestins and β-adrenergic receptor kinases in the failing human heart. Circ. Res. 74, 206-213.
123. Usui, I., Imamura, T., Babendure, J. L., Satoh, H., Lu, J. C., Hupfeld, C. J. and Olefsky, J. M. (2005) G protein-coupled receptor kinase 2 mediates endothelin-1-induced insulin resistance via the inhibition of both Galphaq/11 and insulin receptor substrate-1 pathways in 3T3-L1 adipocytes. Mol. Endocrinol. 19, 2760-2768.
124. Usui, I., Imamura, T., Huang, J., Satoh, H., Shenoy, S. K., Lefkowitz, R. J., Hupfeld, C. J. and Olefsky, J. M. (2004a) β-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1. Mol. Cell. Biol. 24, 8929-8937.
125. Usui, I., Imamura, T., Satoh, H., Huang, J., Babendure, J. L., Hupfeld, C. J., and Olefsky, J. M. (2004b) GRK2 is an endogenous protein inhibitor of the insulin signaling pathway for glucose transport stimulation. EMBO J. 23, 2821-2829.
126. van Putten, J. P. and Krans, H. M. (1985) Long-term regulation of hexose uptake by isoproterenol in cultured 3T3 adipocytes. Am. J. Physiol. 248, E706-E711.
127. Wallhaus, T. R., Taylor, M., DeGrado, T. R., Russell, D. C., Stanko, P., Nickles, R. J. and Stone, C. K. (2001) Myocardial free fatty acid and glucose use after carvedilol treatment in patients with congestive heart failure. Circulation 103, 2441-2446.
128. Watson, R. T. and Pessin, J. E. (2001) Intracellular organization of insulin signaling and GLUT4 translocation. Recent Prog. Horm. Res. 56, 175-193.
129. White, M. F. and Kahn, C. R. (1994) The insulin signaling system. J. Biol. Chem. 269, 1-4.
130. Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K. and Lefkowitz, R. J. (2007) A unique mechanism of β-blocker action: carvedilol stimulates β-arrestin signaling. Proc. Natl. Acad. Sci. U.S.A. 104, 16657-16662.
131. Witteles, R. M. and Fowler, M. B. (2008) Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J. Am. Coll. Cardiol. 51, 93-102.
132. Yamada, K., Ishiyama-Shigemoto, S., Ichikawa, F., Yuan, X., Koyanagi, A., Koyama, W. and Nonaka, K. (1999) Polymorphism in the 5’-leader cistron of the β2-adrenergic receptor gene associated with obesity and type 2 diabetes. J. Clin. Endocrinol. Metab. 84, 1754-1757.
133. Yoo, B., Lemaire, A., Mangmool, S., Wolf, M. J., Curcio, A., Mao, L. and Rockman, H. A. (2009) β1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 297, H1377-H1386.
134. Yu, Q., Gao, F. and Ma, X. L. (2011) Insulin says NO to cardiovascular disease. Cardiovasc. Res. 89, 516-524.
135. Zhao, F. Q. and Keating, A. F. (2007) Functional properties and genomics of glucose transporters. Curr. Genomics 8, 113-128.
136. Zhu, W. Z., Wang, S. Q., Chakir, K., Yang, D., Zhang, T., Brown, J. H., Devic, E., Kobilka, B. K., Cheng, H. and Xiao, R. P. (2003) Linkage of β1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. J. Clin. Invest. 111, 617-625.